Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Obtain and Provide Ordered Controlled Medication for Resident With Behavioral Symptoms

Bradenton, Florida Survey Completed on 03-09-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a prescribed controlled medication, clonazepam 0.5 mg, was available for a resident with Parkinsonism, anxiety disorder, and non-Alzheimer’s dementia with behavioral disturbance. The resident was admitted with a hospital discharge order for clonazepam 0.5 mg PO daily PRN for anxiety, and the facility’s physician orders dated 02/14/2026 reflected clonazepam 0.5 mg every 24 hours PRN for anxiousness related to anxiety disorder for 14 days. The resident’s MDS showed moderate cognitive impairment (BIMS score of 9) and active diagnoses of non-Alzheimer’s dementia and anxiety disorder. Despite these orders, the contracted pharmacy confirmed that no prescription for clonazepam was received before 02/20/2026, and the medication was not delivered to the facility until 02/21/2026. During this period without the ordered clonazepam available, documentation showed behavioral issues. A CNA note from 02/17/2026 at 02:00 a.m. described the resident as agitated and hitting staff, which triggered an alert on the facility’s EMR dashboard and was discussed in the morning clinical meeting. On 02/20/2026 at 03:33 a.m., an RN documented that the resident was combative with care, had smeared bowel movement on himself and the bed, and that although there was an order for clonazepam 0.5 mg PRN, there was “no script”; the pharmacy was called and the primary physician was made aware. A psychiatric ARNP visit on 02/20/2026 noted the resident was being followed for psychotropic medication management due to dementia with inappropriate behavior and resistance to ADL care at night, and the plan was to continue clonazepam 0.5 mg PO every 24 hours PRN for 14 days as currently prescribed. The facility’s own policy required compliance with all laws and requirements related to handling and documentation of controlled substances, yet the ordered controlled medication was not obtained and available for use until several days after admission.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙